| Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. MD Dial S, Alrasadi K, Manoukian C, Huang A Canadian Medical Association Journal, 2004 | 762* | 2004 |
| Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel Expert Opin Drug Saf. 14 (6), 935-955, 2015 | 581* | 2015 |
| Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci. 11 (1), 1-23, 2015 | 581* | 2015 |
| Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe … RD Santos, SS Gidding, RA Hegele, MA Cuchel, PJ Barter, GF Watts, ... The lancet Diabetes & endocrinology 4 (10), 850-861, 2016 | 386 | 2016 |
| Potential effects of curcumin in the treatment of COVID‐19 infection F Zahedipour, SA Hosseini, T Sathyapalan, M Majeed, T Jamialahmadi, ... Phytotherapy Research 34 (11), 2911-2920, 2020 | 347 | 2020 |
| Statins and the COVID-19 main protease: in silico evidence on direct interaction Ž Reiner, M Hatamipour, M Banach, M Pirro, K Al-Rasadi, T Jamialahmadi, ... Archives of Medical Science 16 (3), 490-496, 2020 | 289 | 2020 |
| Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways K Koushki, SK Shahbaz, K Mashayekhi, M Sadeghi, ZD Zayeri, MY Taba, ... Clinical reviews in allergy & immunology 60, 175-199, 2021 | 257 | 2021 |
| Familial hypercholesterolaemia: a global call to arms AJ Vallejo-Vaz, SRK Seshasai, D Cole, GK Hovingh, JJP Kastelein, ... Atherosclerosis 243 (1), 257-259, 2015 | 206 | 2015 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 203 | 2021 |
| Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ... Atherosclerosis 277, 234-255, 2018 | 202 | 2018 |
| Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action KA Wilemon, J Patel, C Aguilar-Salinas, CD Ahmed, M Alkhnifsawi, ... JAMA cardiology 5 (2), 217-229, 2020 | 186 | 2020 |
| Estimated glomerular filtration rate (eGFR): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice ARD Mula-Abed WA, Al Rasadi K Oman medical journal 27 (4), 339, 2012 | 129* | 2012 |
| The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: a consensus statement from the … JC Fruchart, RD Santos, C Aguilar-Salinas, M Aikawa, K Al Rasadi, ... Cardiovascular diabetology 18, 1-20, 2019 | 126 | 2019 |
| Vascular calcifications in homozygote familial hypercholesterolemia Z Awan, K Alrasadi, GA Francis, RA Hegele, R McPherson, J Frohlich, ... Arteriosclerosis, thrombosis, and vascular biology 28 (4), 777-785, 2008 | 125 | 2008 |
| Natural approaches in metabolic syndrome management AM Patti, K Al-Rasadi, RV Giglio, D Nikolic, C Mannina, G Castellino, ... Archives of medical science: AMS 14 (2), 422, 2018 | 123 | 2018 |
| Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) N Danchin, W Almahmeed, K Al-Rasadi, J Azuri, A Berrah, CA Cuneo, ... European journal of preventive cardiology 25 (10), 1087-1094, 2018 | 117 | 2018 |
| Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS … AJ Vallejo-Vaz, A Akram, SRK Seshasai, D Cole, GF Watts, GK Hovingh, ... Atherosclerosis Supplements 22, 1-32, 2016 | 113 | 2016 |
| 2023 update on European Atherosclerosis Society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance M Cuchel, FJ Raal, RA Hegele, K Al-Rasadi, M Arca, M Averna, ... European heart journal 44 (25), 2277-2291, 2023 | 106 | 2023 |
| International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia GF Watts, SS Gidding, RA Hegele, FJ Raal, AC Sturm, LK Jones, ... Nature Reviews Cardiology 20 (12), 845-869, 2023 | 88 | 2023 |
| Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels? AFG Cicero, F Fogacci, AP Stoian, M Vrablik, K Al Rasadi, M Banach, ... Current atherosclerosis reports 23, 1-14, 2021 | 85 | 2021 |
Maciej BanachVice-Rector, Catholic University of Lublin; President, International Lipid Expert Panel, Poland在 umed.lodz.pl 的电子邮件经过验证
